Is Dermatofibrosarcoma Protuberans (DFSP) hereditary?

Dermatofibrosarcoma protuberans (DFSP) is not considered a hereditary condition, meaning it is not passed down from parents to children through germline genetics. Instead, Dermatofibrosarcoma protuberans (DFSP) arises from a somatic (acquired) genetic mutation that occurs in a single cell during a person's lifetime, meaning it is not present in the eggs or sperm.

Is Dermatofibrosarcoma protuberans (DFSP) hereditary?

No, Dermatofibrosarcoma protuberans (DFSP) is not a hereditary disease. It is classified as a sporadic cancer, meaning the genetic changes responsible for the tumor development happen spontaneously within the body's cells after birth. Because these mutations are restricted to the tumor tissue itself, they cannot be passed on to offspring.

What causes the genetic changes in Dermatofibrosarcoma protuberans (DFSP)?

The hallmark of Dermatofibrosarcoma protuberans (DFSP) is a specific chromosomal translocation, most commonly a reciprocal translocation between chromosomes 17 and 22, denoted as t(17;22)(q22;q13). This rearrangement results in the fusion of the COL1A1 and PDGFB genes, leading to the overproduction of platelet-derived growth factor. This is a de novo somatic event, not an inherited one.

Is genetic testing recommended for family members?

Because Dermatofibrosarcoma protuberans (DFSP) is not hereditary, genetic counseling and testing are generally not required for family members or children of an affected individual. The following points summarize the genetic nature of the condition:

• Somatic Mutations: The genetic markers found in Dermatofibrosarcoma protuberans (DFSP) are acquired, not inherited.


• Risk to Offspring: There is no increased risk of passing this condition to children compared to the general population.


• Diagnostic Testing: Molecular genetic testing (such as FISH or RT-PCR) is used to confirm the diagnosis of Dermatofibrosarcoma protuberans (DFSP) by identifying the COL1A1-PDGFB fusion, but this is done on tumor tissue, not blood samples for hereditary screening.

Next steps

• Consult with a board-certified dermatologist or an oncologist specializing in soft tissue sarcomas for diagnosis and management.


• Join our community of 172 members at DiseaseMaps.org to connect with others who have navigated a diagnosis of Dermatofibrosarcoma protuberans (DFSP).


• Focus on routine skin examinations, as early detection of any new or changing skin lesion is the best practice for general health.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always consult with a qualified healthcare professional regarding your specific medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Dermatofibrosarcoma protuberans.


• Orphanet: Dermatofibrosarcoma protuberans (ORPHA:2276).


• OMIM (Online Mendelian Inheritance in Man): COL1A1-PDGFB fusion gene in DFSP.


• National Cancer Institute (NCI): Soft Tissue Sarcoma Treatment.